Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Aging|October 27, 2010
Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing pathsMarjon A Smit, Daniel S PeeperCancer Cell|July 5, 2008
Deregulating EMT and senescence: double impact by a single twistMarjon A Smit, Daniel S PeeperMolecular and Cellular Biology|May 6, 2009
A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasisMarjon A Smit, Thomas R Geiger, Ji-Ying Song, et al.Endocrine Reviews|May 14, 2019
Clinical Guidelines and PTH Measurement: Does Assay Generation Matter?Marjon A Smit, Caroline M J van Kinschot, Joke van der Linden, et al.Blood|November 20, 2015
Primary acute myeloid leukemia cells with overexpression of EVI-1 are sensitive to all-trans retinoic acidHan J M P Verhagen, Marjon A Smit, Arjo Rutten, et al.Molecular Systems Biology|December 25, 2014
ROCK1 is a potential combinatorial drug target for BRAF mutant melanomaMarjon A Smit, Gianluca Maddalo, Kylie Greig, et al.Genes & Development|May 3, 2012
Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesisLiesbeth C W Vredeveld, Patricia A Possik, Marjon A Smit, et al.Pigment Cell & Melanoma Research|March 3, 2015
Cooperative induction of apoptosis in NRAS mutant melanoma by inhibition of MEK and ROCKCelia J Vogel, Marjon A Smit, Gianluca Maddalo, et al.Pigment Cell & Melanoma Research|April 18, 2013
Genome-wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanomaLinda Gao, Marjon A Smit, Joost J van den Oord, et al.Cell Reports|December 3, 2014
Parallel in vivo and in vitro melanoma RNAi dropout screens reveal synthetic lethality between hypoxia and DNA damage response inhibitionPatricia A Possik, Judith Müller, Carmen Gerlach, et al.Pageof 2